Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · January 19, 2023

Comparative Efficacy of Low-Dose Rosuvastatin vs Placebo and Dietary Supplements in Reducing the Levels of Lipids and Inflammatory Biomarkers

Journal of the American College of Cardiology

 

Additional Info

Journal of the American College of Cardiology
Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers
J Am Coll Cardiol 2023 Jan 03;81(1)1-12, LJ Laffin, D Bruemmer, M Garcia, DM Brennan, E McErlean, DS Jacoby, ED Michos, PM Ridker, TY Wang, KE Watson, HG Hutchinson, SE Nissen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading